Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Northwest Biotherapeutics's price to sales ratio was 119.2× on Oct 19, 2026, against 330.0× a year earlier. Over the last 5 years it ranged from 0.0× to 483.6×, with a median of 255.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 119.2× | −251.5 |
| 2025 | Dec 31, 2025 | 370.7× | +149.2 |
| 2024 | Dec 31, 2024 | 221.4× | −163.2 |
| 2023 | Dec 29, 2023 | 384.6× | +384.6 |
| 2022 | Dec 30, 2022 | 0.0× | −483.6 |
| 2021 | Dec 31, 2021 | 483.6× | +94.8 |
| 2020 | Oct 30, 2020 | 388.8× | +246.3 |
| 2019 | Jan 31, 2019 | 142.5× | +22.8 |
| 2018 | Dec 31, 2018 | 119.7× | +0.4 |
| 2017 | Dec 29, 2017 | 119.3× | +89.4 |
| 2016 | Dec 30, 2016 | 29.9× | −113.2 |
| 2015 | Dec 31, 2015 | 143.1× | −344.7 |
| 2014 | May 30, 2014 | 487.8× | +308.9 |
| 2013 | Dec 31, 2013 | 178.9× | +178.8 |
| 2012 | Dec 31, 2012 | 0.1× | −3.4 |
| 2011 | Dec 30, 2011 | 3.5× | – |
See a number that looks wrong?